New ISSCR guidelines: clinical translation of stem cell research

[1]  Richard T. Lee,et al.  Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines , 2016, Stem cell reports.

[2]  L. Turner.  US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions. , 2015, Regenerative medicine.

[3]  Seth M Steinberg,et al.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial , 2015, The Lancet.

[4]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[5]  J. Couzin-Frankel.  The elusive heart fix. , 2014, Science.

[6]  David Moher,et al.  Reducing waste from incomplete or unusable reports of biomedical research , 2014, The Lancet.

[7]  S. Roberts,et al.  How should we assess the safety of IVF technologies? , 2013, Reproductive biomedicine online.

[8]  D. Howells,et al.  Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies , 2013, PLoS biology.

[9]  D. Cyranoski.  Japan to offer fast-track approval path for stem cell therapies , 2013, Nature Medicine.

[10]  D. Magnus.  Translating Stem Cell Research: Challenges at the Research Frontier , 2010, Journal of Law, Medicine & Ethics.

[11]  M. Emborg,et al.  Beyond Access vs. Protection in Trials of Innovative Therapies , 2010, Science.

[12]  B. Freedman.  Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.